(Q43290322)

18 November 2017

title

FK506 as an adjuvant of tolerogenic DNA vaccination for the prevention of experimental autoimmune encephalomyelitis (English)

1 reference

18 November 2017

Youmin Kang

1

1 reference

18 November 2017

Jia Zhao

2

1 reference

18 November 2017

Yue Liu

3

1 reference

18 November 2017

Aoshuang Chen

4

1 reference

18 November 2017

Guoxing Zheng

5

1 reference

18 November 2017

Yang Yu

6

1 reference

18 November 2017

Jianjie Mi

7

1 reference

18 November 2017

Qiang Zou

8

1 reference

18 November 2017

Bin Wang

9

1 reference

18 November 2017

publication date

1 November 2009

1 reference

18 November 2017

published in

Journal of Gene Medicine

1 reference

18 November 2017

volume

11

1 reference

18 November 2017

issue

11

1 reference

18 November 2017

page(s)

1064-1070

1 reference

Suppressive DNA vaccination in myelin oligodendrocyte glycoprotein peptide-induced experimental autoimmune encephalomyelitis involves a T1-biased immune response

18 November 2017

cites work

1 reference

Contrasting impacts of immunosuppressive agents (rapamycin, FK506, cyclosporin A, and dexamethasone) on bidirectional dendritic cell-T cell interaction during antigen presentation

21 January 2018

1 reference

Cutting edge: Immunosuppressant as adjuvant for tolerogenic immunization

21 January 2018

1 reference

De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JGM.1387

1 reference

18 November 2017

1 reference